Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026)
Protalix BioTherapeutics (PLX) recorded quarterly Interest & Investment Income of $188000.0 in Q1 2026, down 29.32% quarter-over-quarter from $266000.0 in Q4 2025, and down 55.13% on a YoY basis from $419000.0 in Q1 2025.
Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Protalix BioTherapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $188000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 55.13% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $1.0 million (down 23.91% YoY), while the FY2025 annual figure was $1.1 million, down 16.63% from the prior year.
- Interest & Investment Income was $188000.0 for Q1 2026 at Protalix BioTherapeutics, down from $266000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $419000.0 in Q1 2025 to a low of $188000.0 in Q1 2026.
- Historically, Interest & Investment Income has averaged $293625.0 across 3 years, with a median of $280500.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income surged 36.32% in 2025, then tumbled 55.13% in 2026.
- A 3-year view of Interest & Investment Income shows it stood at $329000.0 in 2024, then declined by 19.15% to $266000.0 in 2025, then decreased by 29.32% to $188000.0 in 2026.
- The last three Interest & Investment Income figures came in at $188000.0 (Q1 2026), $266000.0 (Q4 2025), and $289000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Protalix BioTherapeutics | 176.47 Mn | 165.67 Mn | 29.62 Mn | 188,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 266,000.00 |
| Sep 30, 2025 | 289,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 212,000.00 |
| Jun 30, 2024 | 374,000.00 |